Literature DB >> 2339353

The increasing prevalence of haemophilia.

F R Rosendaal, E Briët.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2339353

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  7 in total

Review 1.  Hemophilia treatment in historical perspective: a review of medical and social developments.

Authors:  F R Rosendaal; C Smit; E Briët
Journal:  Ann Hematol       Date:  1991-02       Impact factor: 3.673

2.  Pediatric requirements in Europe stymie help for hemophilia.

Authors:  Flora Peyvandi; Frits R Rosendaal; Brian O'Mahony; Pier Mannuccio Mannucci
Journal:  Nat Med       Date:  2014-02       Impact factor: 53.440

3.  Functional factor VIII made with von Willebrand factor at high levels in transgenic milk.

Authors:  S W Pipe; H Miao; S P Butler; J Calcaterra; W H Velander
Journal:  J Thromb Haemost       Date:  2011-11       Impact factor: 5.824

4.  Parental origin of factor IX gene mutations, and their distribution in the gene.

Authors:  M Ludwig; T Grimm; H H Brackmann; K Olek
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

5.  Social/economic costs and quality of life in patients with haemophilia in Europe.

Authors:  Marianna Cavazza; Yllka Kodra; Patrizio Armeni; Marta De Santis; Julio López-Bastida; Renata Linertová; Juan Oliva-Moreno; Pedro Serrano-Aguilar; Manuel Posada-de-la-Paz; Domenica Taruscio; Arrigo Schieppati; Georgi Iskrov; László Gulácsi; Johann Matthias Graf von der Schulenburg; Panos Kanavos; Karine Chevreul; Ulf Persson; Giovanni Fattore
Journal:  Eur J Health Econ       Date:  2016-04-05

6.  Measurement of plasma and platelet tissue factor pathway inhibitor, factor V and Protein S in people with haemophilia.

Authors:  Paul E R Ellery; Ida Hilden; Peter Thyregod; Nicholas D Martinez; Susan A Maroney; Joan C Gill; Alan E Mast
Journal:  Haemophilia       Date:  2019-10-14       Impact factor: 4.287

7.  The health and economic burden of haemophilia in Belgium: a rare, expensive and challenging disease.

Authors:  Séverine Henrard; Brecht Devleesschauwer; Philippe Beutels; Michael Callens; Frank De Smet; Cedric Hermans; Niko Speybroeck
Journal:  Orphanet J Rare Dis       Date:  2014-03-21       Impact factor: 4.123
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.